UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $9.22 Million Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 24.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 118,113 shares of the company's stock after acquiring an additional 23,334 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.24% of Prestige Consumer Healthcare worth $9,223,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in PBH. Franklin Resources Inc. increased its holdings in shares of Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after acquiring an additional 150 shares in the last quarter. CIBC Private Wealth Group LLC lifted its position in shares of Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after buying an additional 152 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in Prestige Consumer Healthcare by 3.3% during the 4th quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock worth $429,000 after purchasing an additional 176 shares in the last quarter. O Shaughnessy Asset Management LLC lifted its holdings in Prestige Consumer Healthcare by 3.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after purchasing an additional 207 shares in the last quarter. Finally, Summit Investment Advisors Inc. increased its stake in Prestige Consumer Healthcare by 4.2% in the 4th quarter. Summit Investment Advisors Inc. now owns 5,182 shares of the company's stock worth $405,000 after acquiring an additional 211 shares during the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at $1,544,130. This trade represents a 8.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on PBH. Royal Bank of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Canaccord Genuity Group boosted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a report on Friday, February 7th. DA Davidson boosted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Oppenheimer boosted their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Finally, Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Down 0.2%

NYSE PBH traded down $0.16 during trading hours on Monday, hitting $85.51. 291,284 shares of the company's stock were exchanged, compared to its average volume of 298,505. The business's 50 day moving average is $83.59 and its 200-day moving average is $82.42. The firm has a market capitalization of $4.23 billion, a P/E ratio of 20.03, a price-to-earnings-growth ratio of 2.69 and a beta of 0.44. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. Prestige Consumer Healthcare Inc. has a 12-month low of $63.02 and a 12-month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Prestige Consumer Healthcare's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.02 EPS. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.